Makers and distributors of the prescription opioids that triggered a U.S. public health crisis are responsible for a rise in health-insurance premiums, according to first-of-their-kind lawsuits filed in five states.
Opioid makers and distributors, including Purdue Pharma and McKesson Corp., were slapped with first-of-their-kind proposed class actions in five federal courts Wednesday alleging that by fueling the nation’s opioid crisis, they have made health care costs go up and health insurance premiums skyrocket.
The opioid epidemic has unfairly increased health insurance costs across the board, not just for those suffering from addiction, plaintiffs allege in five proposed class-action lawsuits filed Wednesday.
Philadelphia-based Uber limo drivers told the Third Circuit on Wednesday that Uber exploited drivers by misclassifying them as independent contractors to dodge paying minimum and overtime wages, and that a district court improperly ruled that the drivers didn’t count as employees under the Fair Labor Standards Act.
A new wave of plaintiffs have joined the opioid-epidemic litigation with five class actions filed on Tuesday: consumers who claim they’re seeing skyrocketing health insurance costs as a result of the crisis.
Montgomery McCracken Walker & Rhoads LLP on Tuesday said a $620 million malpractice suit it recently removed from Pennsylvania state court should remain in a federal judge’s hands thanks to its genesis in a bankruptcy proceeding that a group of Luzerne County residents say shortchanged their toxic tort claims against […]
A group of Abbvie investors who say they and others like them collectively lost more than $100 million when the pharmaceutical giant used an after-hours press release to adjust a share price tender offer, has sued the company in a federal securities class action filed July 26 in Chicago.
An investor hit Tesla Inc. and its founder Elon Musk with a proposed securities fraud class action Friday in California federal court, claiming they tried to pump up stock prices by proclaiming plans to take the company private — without having the more than $71 billion privatizing would require.
A proposed class of AbbVie Inc. investors filed a stock drop suit against the pharmaceutical company in Illinois federal court Thursday, saying a corrective disclosure related to the company’s May stock buyback efforts led to a collective $100 million loss in value for the shareholders.
As founders of one of the first and biggest litigation funding companies, the founders behind what was once Gerchen Keller Capital (GKC) became known for bringing financial innovation to a staid profession’s books. Now, they’re taking on the opioid crisis by putting a new twist on an en vogue type […]